{"groups":[{"description":"Participants will receive obinutuzumab for 6 cycles and chlorambucil for 12 cycles. Cycles will comprise 28 days.","id":"FG000","title":"Obinutuzumab + Chlorambucil"},{"description":"Participants will receive obinutuzumab for 6 cycles and venetoclax for 12 cycles. Cycles will comprise 28 days.","id":"FG001","title":"Obinutuzumab + Venetoclax"},{"description":"Subjects received obinutuzumab for 6 cycles and venetoclax for 12 cycles. Cycles comprised of 28 days.","id":"FG002","title":"Safety Run-in Obinutuzumab + Venetoclax"}],"periods":[{"dropWithdraws":[{"reasons":[{"groupId":"FG000","numSubjects":"17"},{"groupId":"FG001","numSubjects":"20"},{"groupId":"FG002","numSubjects":"2"}],"type":"Death"},{"reasons":[{"groupId":"FG000","numSubjects":"1"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"}],"type":"Physician Decision"},{"reasons":[{"groupId":"FG000","numSubjects":"8"},{"groupId":"FG001","numSubjects":"10"},{"groupId":"FG002","numSubjects":"0"}],"type":"Withdrawal by Subject"},{"reasons":[{"groupId":"FG000","numSubjects":"190"},{"groupId":"FG001","numSubjects":"186"},{"groupId":"FG002","numSubjects":"11"}],"type":"On-going in Study"}],"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"216"},{"groupId":"FG001","numSubjects":"216"},{"groupId":"FG002","numSubjects":"13"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"214"},{"groupId":"FG001","numSubjects":"212"},{"groupId":"FG002","numSubjects":"13"}],"type":"Treated"},{"achievements":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"216"},{"groupId":"FG001","numSubjects":"216"},{"groupId":"FG002","numSubjects":"13"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}]}